| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 0.05 | 0.00 (0.00%) | 0.025 - 0.25 | 0.0 |
Market data as of 12:00AM 05/20/13. Quotes are delayed by at least 15 min.
| Open | -- |
|---|---|
| Previous Close | 0.05 |
| Day's Range | -- - -- |
| Market Cap | 3.9M |
| Avg Volume (10 Day) | 1.3M |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Neutral |
|---|---|
| Avoids excess debt? | Neutral |
| Converting sales to profits? | Neutral |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Neutral |
| Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Neutral |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Neutral |
| Have investors caught on? | Neutral |
| Has support of institutional investors? | Neutral |
| Has sufficient liquidity? | Neutral |
The X-Change Corporation Continues New Product Development Progress Simultaneously with European Line and Extract-Based Products
PR Newswire - Monday 05/20/2013 8:59 AM ET
X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
PR Newswire - Wednesday 05/15/2013 3:03 PM ET
XCHC to Launch its New Website at 11:00am PDT Today, Critical Ailment Information, Patient Tracking Resources, Cannabinoid Research Platforms, and Patient-to-Patient Information Exchange
PR Newswire - Wednesday 05/15/2013 9:08 AM ET
XCHC Announces Appointment of Doctorandus Mario Lap as Director of European Operations, as the Company Solidifies Expansion in Europe for Immediate Product Release to European and North American Consumers
PR Newswire - Wednesday 05/08/2013 8:38 AM ET
XCHC Issues Weighted Performance Guidance for New Product Releases, Operational Expansion, and Corporate Developments
PR Newswire - Monday 05/06/2013 9:36 AM ET
XCHC Reports on 'American Drug War 2' National Theatrical Release on June 6, 2013; TheStockRadio.com Interview With Kevin Booth
PR Newswire - Thursday 05/02/2013 10:40 AM ET
| XCHC | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -- | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | -- |
| Company | Last | Change |
|---|
Data is delayed by at least 15 min.